Life Science Today

Life Science Today

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Episodes

November 22, 2022 6 min

A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Indivior + Opiant
Regeneron + CytomX
Rezo
Provention

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the m...

Mark as Played

More CRISPR data, oncology wins, and a new player in ophthalmology

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Intellia
Regeneron
Viatris + Oyster Point

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private e...

Mark as Played

Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Sumitovant + Myovant
Thermo Fisher + Binding Site Group
Astellas & Taysha
Agios
Vaxctye

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmace...

Mark as Played

Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
FDA
AbbVie + DJS
Roche + Hookipa
Kyverna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about ...

Mark as Played
October 18, 2022 7 min

One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news


Find out more at
https://LifeScienceTodayPodcast.com

Story References
DICE
Odyssey
Fred Hutch
Merck (MSD), Merck Story 2

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, ne...

Mark as Played
October 11, 2022 6 min

Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Nested Therapeutics
Cellarity
Replimune
Estrella Biopharma

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions,...

Mark as Played

Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Eisai + Biogen
Amylyx
Sanofi + Regeneron

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture c...

Mark as Played

A $900 raise, gene therapy news, a quick IPO, and merge three for $100M

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Alnylam, Link 2, Link 3
Intellia Therapeutics
Third Harmonic Bio
Galvanize Therapeutics

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news ab...

Mark as Played

A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Revance
Velocity + MedPharmics
Arsenal
SpringWorks Link 1, Link 2, Link 3

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceuti...

Mark as Played

A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Novo + Forma
Sanofi
Boehringer Ingelheim
Arcturus


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital an...

Mark as Played

Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Alcon + Aerie
Novartis + Sandoz
Labcorp + RWJBH

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acqui...

Mark as Played

Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Bluebird
Endo & Pharmacies
Genentech + Jemincare
Merck + Orna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, new...

Mark as Played

Spending that COVID money, brain money, Irish money, and another oncology approval.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Pfizer
Cerevel
Abbott
AstraZeneca + Daiichi Sankyo

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of ven...

Mark as Played
August 2, 2022 7 min

This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives?
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Zymergen + Ginkgo
Cassava
Teva

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly...

Mark as Played

There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As

Find out more at
https://LifeScienceTodayPodcast.com

Story References
ZyVersa
Incyte
Revolution
Frontera
CAMP4
ForSight
Auron

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capi...

Mark as Played

Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Vertex + ViaCyte
Theravance Biopharma
Merck + Orion
Pliant Therapeutics
Qiming

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutic...

Mark as Played

FEED DROP - Clinical Research Evolved

Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.

Find Out More
Dan Agroskin
Clinical Research Evolved
Noah Goodson, PhD
John Reites
Kyle Ricketts




About the Show
...

Mark as Played

Double acquisition, private money, affordable deals, and a surprising $70M launch

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Galapagos + CellPoint + AboundBio
Radius
Ipsen + Epizyme
DEM Bio

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news ab...

Mark as Played

Crohn’s approval, new VC round, direct offerings, and potential asset sales.
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
AbbVie
Third Rock
Scholar Rock
Kyowa Kirin

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and p...

Mark as Played

Gene therapy, minor legislation, a $625M series D, and four companies raise $373M.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
BlueBird
FDA
Resilience
Corvia, Code, Mineralys, Tessa

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of vent...

Mark as Played

Popular Podcasts

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

    Crime Junkie

    If you can never get enough true crime... Congratulations, you’ve found your people.

    The Piketon Massacre

    The most notorious mass murder in Ohio’s history happened on the night of April 21, 2016 in rural Pike County. Four crime scenes, thirty-two gunshot wounds, eight members of the Rhoden family left dead in their homes. Two years later a local family of four, the Wagners, are arrested and charged with the crimes. As the Wagners await four back-to-back capital murder trials, the KT Studios team revisits Pike County to examine: crime-scene forensics, upcoming legal proceedings, and the ties that bind the victims and the accused. As events unfold and new crimes are uncovered, what will it mean for all involved? What will it mean for Pike County?

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.

    Morbid

    It’s a lighthearted nightmare in here, weirdos! Morbid is a true crime, creepy history and all things spooky podcast hosted by an autopsy technician and a hairstylist. Join us for a heavy dose of research with a dash of comedy thrown in for flavor.

Advertise With Us

For You

    Music, radio and podcasts, all free. Listen online or download the iHeart App.

    Connect

    © 2022 iHeartMedia, Inc.